Molecular remission using low-dose immunotherapy for relapsed refractory Philadelphia chromosome-positive precursor B-cell acute lymphoblastic leukemia post-allogeneic stem cell transplant

Adults with relapsed/refractory acute lymphoblastic leukemia have a poor prognosis. While current immunotherapies are promising, they are toxic, with graft-versus-host disease a major complication of allogeneic therapy. Here, we report a patient with high-risk relapsed/refractory Philadelphia chromo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Future Sci OA
Hoofdauteurs: Maharaj, Dipnarine, Vianna, Pedro, DeCarvalho, Gabriel, Pourkalbassi, Delaram, Hickey, Christopher, Gouvea, Jacqueline
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Future Science Ltd 2019
Onderwerpen:
Case Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554698/
https://ncbi.nlm.nih.gov/pubmed/31245042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2144/fsoa-2019-0009
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items